GOAL
To inform and educate specialty and managed care pharmacists about the use of PARP inhibitors in ovarian cancer, their differences and similarities, evidence to ensure appropriate access to treatment and strategies to ensure effective patient care thus leading to optimized outcomes.
EDUCATIONAL OBJECTIVES
Upon completion of this program, participants should be better able to:
-Discuss the safety and efficacy of PARP inhibitors in ovarian cancer
-Compare and contrast available PARP inhibitors in the personalized treatment of patients with ovarian cancer
-Demonstrate effective strategies to optimize oral pharmacotherapy for patients with ovarian cancer including adherence and adverse event management
TARGET AUDIENCE
This accredited activity has been designed for managed care and specialty pharmacists.